Psychedelic Drugs Market Strategic Insights and key Business Influencing Factors | Major Players – Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma SA, COMPASS, usonainstitute.org.
Psychedelic Drugs Marketare used to enhance or change sensory perceptions, energy levels, thought processes, and to facilitate spiritual experiences. Psychedelic drugs can be categorized into dissociative drugs (such as PCP), empathogens and serotonergic (classic hallucinogens) (such as LSD). These drugs are used in the treatment of major depressive disorder, treatment-resistant depression, panic disorder, post-traumatic stress disorder, and opiate addiction among others.
Psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=us-psychedelic-drugs-market
Competitive Analysis: U.S Psychedelic Drugs Market
Few of the major competitors currently working in U.S Psychedelic Drugs Market are Johnson & Johnson Services, Inc., Jazz Pharmaceuticals, Inc., Celon Pharma SA, COMPASS, usonainstitute.org, Develco pharma schweiz ag , Doughlas pharmaceuticals limited, NeuroRX, Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, LLC., AVADEL PHARMACEUTICALS, PLC among other players in the U.S. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Key Pointers Covered in the U.S Psychedelic Drugs Market Trends and Forecast to 2026
- U.S Psychedelic Drugs Market New Sales Volumes
- U.S Psychedelic Drugs Market Replacement Sales Volumes
- U.S Psychedelic Drugs Market Installed Base
- U.S Psychedelic Drugs Market By Brands
- U.S Psychedelic Drugs Market Size
- U.S Psychedelic Drugs Market Procedure Volumes
- U.S Psychedelic Drugs Market Product Price Analysis
- U.S Psychedelic Drugs Market Healthcare Outcomes
- U.S Psychedelic Drugs Market Cost of Care Analysis
- U.S Psychedelic Drugs Market Regulatory Framework and Changes
- U.S Psychedelic Drugs Market Prices and Reimbursement Analysis
- U.S Psychedelic Drugs Market Shares in Different Regions
- Recent Developments for U.S Psychedelic Drugs Market Competitors
- U.S Psychedelic Drugs Market Upcoming Applications
- U.S Psychedelic Drugs Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=us-psychedelic-drugs-market
U.S. Psychedelic Drugs Market Scope and Market Size
- U.S. psychedelic drugs market is segmented on the basis of source, type, application, route of administration, drugs, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of source, the market is segmented into synthetic and natural. Synthetic dominates the psychedelic drugs market as all available drugs are derived from synthetic origin. For this reason, the synthetic segment dominates the market and will also grow at a higher rate over the forecasted period.
Segmentation: U.S Psychedelic Drugs Market
- On the basis of type, the market is segmented into dissociatives, empathogens, and serotonergic (classical psychedelic drugs). The dissociatives segment dominates the psychedelic drugs market as XYREM (sodium oxybate, Jazz Pharmaceuticals Inc.) is the only approved drug of disruptive psychedelics for the treatment of narcolepsy.
- On the basis of application, the market is segmented into narcolepsy, treatment-resistant depression, post-traumatic stress disorder (PTSD), major depressive disorder, others. Narcolepsy as a gamma hydroxybutyric acid (GHB) derivative dominates the psychedelic drugs market and primarily uses psychedelic medicine and the drug has been approved for narcolepsy. Due to this reason, the narcolepsy segment dominates the psychedelic drugs market.
- On the basis of route of administration, the market is segmented into oral, intranasal, parenteral, others. Oral is dominant in the psychedelic drugs market as Xyrem is the most branded drug available in the market in oral dosage forms. In addition, patient adherence is very important in symptomatic treatment of the disease. Oral administration of the drug is highly convenient for patients as compared to other forms.
Inquire Before Buying:
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=us-psychedelic-drugs-market
Key insights in the report:
- Complete and distinct analysis of the market drivers and restraints
- Key Market players involved in this industry
- Detailed analysis of the Market Segmentation
- Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here: